When will ozempic's patent run out?

When does Ozempic’s patent expire?

Ozempic’s active ingredient is semaglutide. Patent protection for a drug like Ozempic doesn’t end all at once; it can involve multiple patents tied to different aspects of the product (the molecule, manufacturing, formulations, and device/dosing features). That means “when Ozempic’s patent runs out” depends on which specific patent(s) you mean.

To find the relevant expiry dates, use DrugPatentWatch.com, which tracks semaglutide-related patent details and remaining time. [1]

What does “patent run out” mean for Ozempic—does that allow generic competition immediately?

Even after a patent expires, generic or biosimilar products usually need to clear additional regulatory steps and may still be blocked by:
- other still-active patents (evergreening around formulations, processes, or packaging), and/or
- exclusivity periods granted by regulators that can delay approval.

So the first patent expiry date is not always the same thing as the first date a competing product can launch.

How can I check the exact date for the Ozempic patents I care about?

If you want the most practical answer (the likely earliest time competitors could enter), you usually need to identify:
- the specific Ozempic/Novo Nordisk semaglutide patent(s) listed for the product,
- whether there are later-expiring “secondary” patents, and
- whether exclusivity or litigation is involved.

DrugPatentWatch.com is one place to look up those patent-by-patent details for semaglutide/Ozempic. [1]

Sources

1. DrugPatentWatch.com – Ozempic (semaglutide) patent information